1. Home
  2. News
  3. Tibet Rhodiola Pharmaceutical Holding Co.
  4. Full Text of 2023 Semi-annual Report
More Tibet Rhodiola Pharmaceutical Holding Co. news
Tibet Rhodiola Pharmaceutical Holding Co.SSE: 600211

Full Text of 2023 Semi-annual Report

Aug 14, 2024 · Issued by Tibet Rhodiola Pharmaceutical Holding Co. via Shanghai Stock Exchange

Filed with SSE · Aug 14, 2024

On 6ix: 6ix.com/news/full-text-of-2023-semi-annual-report

Full Text of 2023 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Tibet Rhodiola Pharmaceutical Holding Co. on 6ix

Earlier from Tibet Rhodiola Pharmaceutical

  • Announcement on Progress in Implementation of Significant Assets ReorganizationJun 29, 2024
  • Announcement on Result of Judicial Enforcement of Some Shares Held by Shareholder with Over 5% SharesJun 7, 2024

Later from Tibet Rhodiola Pharmaceutical

  • Announcement on the Implementation of 2024 Semi-annual Equity DistributionAug 22, 2024
  • Announcement on Progress in Implementation of Significant Asset RestructuringSep 28, 2024
  • Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)Oct 15, 2024
  • Announcement on Convening Semi-annual and Q3 2024 Performance BriefingOct 26, 2024
  • Report for Q3 2024Oct 30, 2024
All Tibet Rhodiola Pharmaceutical news releases↗

Follow Tibet Rhodiola Pharmaceutical into a list and get an email when it puts out news.

Follow Tibet Rhodiola Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer